Blacksmith Medicines announces oncology scientific advisorsblacksmithmed2023-01-05T06:02:55-08:0001.05.2023|
Blacksmith Medicines announces merger with Forge Therapeutics to create leading company developing medicines targeting metalloenzymesblacksmithmed2023-01-04T12:39:59-08:0001.02.2023|
Blacksmith Medicines launches with seed funding and a research collaboration with Lillyblacksmithmed2023-01-04T13:08:03-08:0001.08.2021|